Oneview Healthcare H1 Loss Worsens Challenging Bullish Revenue Growth Narratives

Simply Wall St.

Feb 13

Oneview Healthcare (ASX:ONE) has put fresh numbers on the table for FY 2025, reporting first half revenue of €6.3 million and a basic EPS loss of €0.01. Trailing twelve month revenue stands at €11.6 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2611471151"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2611471151\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2611471151?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","is_english":true,"pubTime":"2026-02-13 16:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2611471151","market":"us","top_or_hot":-1,"title":"Oneview Healthcare H1 Loss Worsens Challenging Bullish Revenue Growth Narratives","media":"Simply Wall St.","content":"<div>\n<p>Oneview Healthcare (ASX:ONE) has put fresh numbers on the table for FY 2025, reporting first half revenue of €6.3 million and a basic EPS loss of €0.01. Trailing twelve month revenue stands at €11.6 ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-one/oneview-healthcare-shares/news/oneview-healthcare-h1-loss-worsens-challenging-bullish-reven\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oneview Healthcare H1 Loss Worsens Challenging Bullish Revenue Growth Narratives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOneview Healthcare H1 Loss Worsens Challenging Bullish Revenue Growth Narratives\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-13 16:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/healthcare/asx-one/oneview-healthcare-shares/news/oneview-healthcare-h1-loss-worsens-challenging-bullish-reven><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oneview Healthcare (ASX:ONE) has put fresh numbers on the table for FY 2025, reporting first half revenue of €6.3 million and a basic EPS loss of €0.01. Trailing twelve month revenue stands at €11.6 ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-one/oneview-healthcare-shares/news/oneview-healthcare-h1-loss-worsens-challenging-bullish-reven\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BLSG","symbol_name":"2倍做多BLSH ETF-Leverage Shares","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-one/oneview-healthcare-shares/news/oneview-healthcare-h1-loss-worsens-challenging-bullish-reven","article_id":"2611471151","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-one/oneview-healthcare-shares/news/oneview-healthcare-h1-loss-worsens-challenging-bullish-reven","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2611471151","pubTimestamp":1770971634,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Oneview Healthcare (ASX:ONE) has put fresh numbers on the table for FY 2025, reporting first half revenue of €6.3 million and a basic EPS loss of €0.01. Trailing twelve month revenue stands at €11.6 million with a basic EPS loss of €0.016452. Over recent periods the company’s revenue has moved from €4.7 million in the first half of 2024 to €5.2 million in the second half of 2024 and then to €6.3 million in the first half of 2025. Across the same periods, half year basic EPS figures have...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BLSG":"2倍做多BLSH ETF-Leverage Shares","BK4581":"高盛持仓","ONE.AU":"Oneview Healthcare","BK4585":"ETF&股票定投概念","LABU":"三倍做多标普生物-Direxion","BK4112":"金融交易所和数据","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","BK7094":"医疗保健技术","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4137":"综合支持服务","BLSX":"Tradr 2X Long BLSH Daily ETF","BK4588":"碎股","XBI":"SPDR S&P Biotech ETF"},"translate_title":"Oneview Healthcare上半年亏损加剧了充满挑战的看涨收入增长叙事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XBI":0.6,"ONE.AU":1.96,"BLSG":0.6,"LABU":0.6,"BLSX":0.6},"content_text":"Oneview Healthcare (ASX:ONE) has put fresh numbers on the table for FY 2025, reporting first half revenue of €6.3 million and a basic EPS loss of €0.01. Trailing twelve month revenue stands at €11.6 million with a basic EPS loss of €0.016452. Over recent periods the company’s revenue has moved from €4.7 million in the first half of 2024 to €5.2 million in the second half of 2024 and then to €6.3 million in the first half of 2025. Across the same periods, half year basic EPS figures have remained in loss territory between about €0.0065 and €0.01. That combination of increasing revenue and ongoing losses leaves margins under pressure and keeps attention on how efficiently the business can scale. See our full analysis for Oneview Healthcare. With the headline numbers laid out, the next step is to consider how this margin picture aligns with the prevailing narratives around Oneview Healthcare's growth potential and risk profile. See what the community is saying about Oneview Healthcare ASX:ONE Earnings & Revenue History as at Feb 2026 AdvertisementLarger Half Year Loss Behind The Revenue Growth  Net income for H1 2025 was a loss of €7.9 million on €6.3 million of revenue, compared with a €5.3 million loss on €5.2 million of revenue in H2 2024. The business is still spending more than it brings in over each half year. Bulls focus on the 31.3% forecast annual revenue growth and argue that operating leverage will eventually help. However, the trailing twelve month loss of €13.2 million against €11.6 million of revenue highlights how far margins need to move before that optimistic view on earnings really lines up with the current income statement.  High Growth Forecasts Versus Persistent Unprofitability  Over the last five years, losses have reportedly grown at about 7.3% per year and models indicate the company is expected to remain unprofitable over the next three years, even though revenue is forecast to grow around 29% per year. Bears point to this combination of strong top line forecasts and ongoing losses as a key concern. The current trailing twelve month basic EPS loss of €0.016452 alongside a short cash runway of under one year reinforces their worry that the business may need more funding before it gets close to break even.  Bears warn that this mix of fast revenue growth and expanding losses could force tough financing choices if execution slips. It is worth reading their full case in 🐻 Oneview Healthcare Bear Case for context around these earnings.\n\nRich P/S Multiple Against Peers  With the share price at A$0.30, the company is trading on a P/S of 11.9x compared with 2.9x for peers and 3.7x for the wider healthcare services industry, and the latest DCF fair value estimate sits at A$0.06. Bullish investors argue that faster forecast revenue growth and product traction justify that higher multiple. Yet the gap between the current price and the A$0.06 DCF fair value, together with the lack of profits, creates a clear tension between paying up for growth and the cautious signals coming from the valuation models.  Supporters of the bullish view see the current multiple as the price of future growth. If you want to see how that story is built around these earnings, check out the detailed bull case in 🐂 Oneview Healthcare Bull Case.  Next Steps To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Oneview Healthcare on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves. See the numbers differently. Take a couple of minutes to weigh the revenue, losses and valuation for yourself, then shape that view into your own narrative with Do it your way. A great starting point for your Oneview Healthcare research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision. Explore Alternatives Oneview Healthcare is growing revenue but still reports sizeable losses, a short cash runway and a P/S multiple well above healthcare services peers. If that mix of ongoing losses and funding risk feels uncomfortable, take a look at our 5 resilient stocks with low risk scores to focus on companies with more resilient risk profiles right now.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}